Inhibition of kinin breakdown prolongs retention and action of bradykinin in a myocardial B 2 receptor compartment

British Journal of Pharmacology

Volumn 138, Issue 2, 2003, Pages 310-316

  Dendorfer, Andreas ^a   Folkers, Verena ^a   Klinger, Matthias ^a   Wolfrum, Sebastian ^a   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Aminopeptidase P; Angiotensin I converting enzyme; B 2 receptors; Bradykinin; Caveolae; Heart; Rat

Indexed keywords

AMINOPEPTIDASE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO HYDROXYPROLYLGLUTAMYLPROPYL OCTAHYDRO 1H INDOLE 2 CARBONYLARGININE]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; NPC 17731; RAMIPRILAT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HALF LIFE TIME; HEART MUSCLE; ISOLATED HEART; KALLIKREIN KININ SYSTEM; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

AMINOPEPTIDASES; ANIMALS; BRADYKININ; ENZYME INHIBITORS; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0037272202     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705036     Document Type: Article

References (34)

1. ANDERSON, R.G., KAMEN, B.A., ROTHBERG, K.G. & LACEY, S.W. (1992). Potocytosis: sequestration and transport of small molecules by caveolae. Science, 255, 410-411.
2. AUCH-SCHWELK, W., BOSSALLER, C., CLAUS, M., GRAF, K., GRÄFE, M. & FLECK, E. (1993). ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin. Cardiovasc. Res., 27, 312-317.
3. 2 kinin receptor within the plasma membrane of native endothelial cells. Circulation, 99, 2034-2040.
4. CHAMBLISS, K.L., YUHANNA, I.S., MINEO, C., LIU, P., GERMAN, Z., SHERMAN, T.S., MENDELSOHN, M.E., ANDERSON, R.G. & SHAUL, P.W. (2000). Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ. Res., 87, E44-E52.
5. 2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem., 272, 17858-17866.
6. DENDORFER, A., REISSMANN, S., WOLFRUM, S., RAASCH, W. & DOMINIAK, P. (2001). Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation. Hypertension. 38, 142-146.
7. DENDORFER, A., WOLFRUM, S., SCHÄFER, U., STEWART, J.M., INAMURA, N. & DOMINIAK, P. (2000). Potentiation of the vascular response to kinins by inhibition of myocardial kininases. Hypertension. 35, 32-37.
8. DENDORFER, A., WOLFRUM, S., WELLHÖNER, P., KORSMAN, K. & DOMINIAK, P. (1997). Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. Br. J. Pharmacol., 122, 1179-1187.
9. DVORAK, A.M. & FENG, D. (2001). The vesiculo-vacuolar organdie (VVO). A new endothelial cell permeability organelle. J. Histochem. Cytochem., 49, 419-432.
10. 2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists. Effect of basal desensitization. J. Biol. Chem., 274, 29603-29606.
11. 2 receptor in rat kidney by anti-peptide and anti-ligand antibodies. J. Histochem. Cytochem., 43, 137-148.
12. 2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin. Can. J. Physiol. Pharmacol., 80, 153-163.
13. GUMBLETON, M., ABULROB, A.G. & CAMPBELL, L. (2000). Caveolae: an alternative membrane transport compartment. Pharm. Res., 17, 1035-1048.
14. 2 receptor in caveolae. J. Cell Sci., 111, 917-928.
15. HECKER, M., BLAUKAT, A., BARA, A.T., MÜLLER-ESTERL, W. & BUSSE, R. (1997). ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br. J. Pharmacol., 121, 1475-1481.
16. 2 receptor is adjacent to a sulfhydryl and is differentiated from the antagonist binding site by chemical cross-linking. J. Biol. Chem., 270, 20591-20598.
17. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KONIG, W. & KNOLLE, J. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
18. 2 receptor. Hypertension, 35, 1319-1325.
19. JU, H., VENEMA, V.J., LIANG, H., HARRIS, M.B., ZOU, R. & VENEMA, R.C. (2000). Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem. J., 351, 257-264.
20. 2 receptor with endothelial nitric-oxide synthase. J. Biol. Chem., 273, 24025-24029.
21. LINZ, W., WIEMER, G., GOHLKE, P., UNGER, T. & SCHÖLKENS, B.A. (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49.
22. 2 bradykinin receptor by ACE inhibitors. J. Biol. Chem., 275, 16110-16118.
23. 2 receptors and angiotensin I-converting enzyme in CHO cells. Circ. Res., 81, 848-856.
24. MUNOZ, C.M. & LEEB-LUNDBERG, L.M. (1992). Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. J. Biol. Chem., 267, 303-309.
25. 2 bradykinin receptor that is essential for high-affinity agonist binding. Proc. Natl. Acad. Sci. U.S.A. 91, 4417-4421.
26. NOGUCHI, Y., SHIBATA, Y. & YAMAMOTO, T. (1987). Endothelial vesicular system in rapid-frozen muscle capillaries revealed by serial sectioning and deep etching. Anat. Rec., 217, 355-360.
27. ORAWSKI, A.T., SUSZ, J.P. & SIMMONS, W.H. (1989). Metabolism of bradykinin by multiple coexisting membrane-bound peptidases in lung: techniques for investigating the role of each peptidase using specific inhibitors. Adv. Exp. Med. Biol., 247B, 355-364.
28. PREDESCU, S.A., PREDESCU, D.N. & PALADE, G.E. (1997). Plasmalemmal vesicles function as transcytotic carriers for small proteins in the continuous endothelium. Am. J. Physiol, 272, H937-H949.
29. REINER, M., BLOCH, W. & ADDICKS, K. (2001). Functional interaction of caveolin-I and eNOS in myocardial capillary endothelium revealed by immunoelectron microscopy. J. Histochem. Cytochem., 49, 1605-1610.
30. RYAN, J.W., RYAN, U.S., SCHULTZ, D.R., WHITAKER, C. & CHUNG, A. (1975). Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem. J., 146, 497-499.
31. SCHAEFFER JR. R.C., GONG, F., BITRICK JR. M.S. & SMITH, T.L. (1993). Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am. J. Physiol., 264, H1798-H1809.
32. SCHNITZER, J.E., OH, P., PINNEY, E. & ALLARD, J. (1994). Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol., 127, 1217-1232.
33. SMART, E.J., YING, Y.S. & ANDERSON, R.G. (1995). Hormonal regulation of caveolae internalization. J. Cell Biol., 131, 929-938.
34. TOM, B., DENDORFER, A., DE VRIES, R., SAXENA, P.R. & DANSER, A.H. (2002). Bradykinin potentiation by ACE inhibitors: A matter of metabolism. Br. J. Pharmacol., 137, 276-284.